I-026

Interference Mix 4 (For Qualitative Use Only)

5-100 μg/mL each component in methanol, Cerilliant^®

• 同義詞: Qualitative Interference Mixture
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: analytical standard
• 品質等級: 100
• 形狀: liquid
• 成份: Alprazolam, 100 μg/mL ; Cimetidine, 100 μg/mL ; Citalopram hydrobromide, 100 μg/mL (as free base); Clonazepam, 100 μg/mL ; Clopidogrel bisulfate, 100 μg/mL (as free base); Dextromethorphan, 50 μg/mL ; Fluconazole, 100 μg/mL ; Hydrochlorothiazide, 100 μg/mL ; Lamotrigine, 100 μg/mL ; Methylphenidate hydrochloride, 100 μg/mL (as free base); Omeprazole, 100 μg/mL ; L-Thyroxine, 5 μg/mL
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• drug control: psicótropo (Spain); Decreto Lei 15/93: Tabela IV/IIB (Portugal)
• 濃度: 5-100 μg/mL each component in methanol
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: forensics and toxicology
• 形式: single component solution
• 儲存溫度: −20°C

描述

一般說明

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs alprazolam; cimetidine; citalopram HBr; clonazepam; clopidogrel bisulfate; dextromethorphan; fluconazole; hydrochlorothiazide; lamotrigine; L-thyroxine; methylphenidate HCl; and omeprazole. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370
• 防範說明: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes,Central nervous system
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup